From Clinical Data to Actionable Assets for Pharmaceutical R&D
In this webinar, learn to transform raw clinical and biobanking data into research-ready assets to accelerate pharmaceutical R&D.
Translational Success in Inflammasome Drug Discovery: How Advanced Models and Integrated Assays Can Reduce Attrition
Join Professor Luke O’Neill (Trinity College Dublin) and Dr Elise Malavasi ( Associate Director of Neurosciences Concept Life Sciences) for this webinar that explores recent advances in inflammasome science, and highlights how selecting appropriate in vitro models and meaningful readouts is essential for accurately assessing therapeutic potential.
Epigenomics at 360° in Liquid Biopsy: Approaches and Case Studies for Biomarker Discovery and Drug Development
Dr. Matteo Tosolini and Dr. Jessica Apulei from Hologic Diagenode answer questions from their webinar on epigenomics as a dynamic regulatory layer beyond genetics and liquid biopsies as a means of obtaining multimodal biomarker readouts.
Advancing the Manufacture of Mesenchymal Stromal Cells and Derived Extracellular Vesicles in Stirred-Tank Bioreactors Through Enhanced Bioprocess Control
Learn how to scale the production of MSCs and extracellular vesicles using bioreactor control and real-time monitoring for more consistent therapies.
Engineering Neuromodulation for Cardiovascular Instability
Dr. Aaron Phillips traces the translational journey of a discovery that began in a foundational laboratory and is now advancing through pivotal clinical trials aimed at stabilizing cardiovascular function.
How to Avoid Expensive Redesign Cycles in Antibody Discovery
Learn how integrated antibody discovery and engineering strategies can accelerate the path from hit to optimized lead in less than 12 months while minimizing costly redesign cycles.
Accelerating Antibody Discovery: Integrating Microfluidics, HT Expression, and Early Developability Platform
In this webinar, Dr. Lei Shi introduces Biointron's antibody discovery platform and applications.
Beyond Exposure: Integrating PK/PD for Translational Predictive Power
Learn to integrate PK/PD modeling and strategic biomarkers to bridge the translational gap. Improve clinical predictability for NCEs, ADCs, and large molecules in this technical webinar.
Illuminating the Brain: Advances in Neurobiology
Watch leading experts in neurobiology imaging in a virtual symposium exploring cutting-edge multi-modal approaches using ultra-high frequency ultrasound and photoacoustics.
Advancing ADC Development: Leveraging AI and Translational Preclinical Models to Improve Clinical Predictability
Join our webinar to discover how to de-risk ADC development through the integration of AI-driven analytics, mouse clinical trials and specialized translational models.
Scaling AAV9 Manufacturing: A Blueprint for Clinical-Grade Gene Therapy Production
Learn how to overcome AAV9 bottlenecks with an open-source, high-yield manufacturing blueprint designed to accelerate clinical-grade gene therapy production.
From Biopsy to Better Decisions: Patient-Derived Organoids Predict Treatment Response in Metastatic Colorectal Cancer
Learn how patient-derived organoids predict treatment response in metastatic colorectal cancer and explore findings from the OPTIC study on drug sensitivity and clinical outcomes.
Accelerating Conjugation Process Development for Next-Generation ADCs: Key Considerations and Platform Strategies
In this webinar, Dr. Peng reviews the current ADC landscape and share key considerations and platform strategies to accelerate conjugation process development for next-gen ADCs.
Epigenomics at 360° in Liquid Biopsy: Approaches and Case Studies for Biomarker Discovery and Drug Development
In this talk, we highlight epigenomics as a dynamic regulatory layer beyond genetics and demonstrate how minimally invasive liquid biopsies can provide multimodal biomarker readouts.
Precision in Human Biological Samples: Leveraging Regulatory Rigor and Deep Data for Advanced Disease Research
In this webinar, experts explore how high-quality biospecimens, longitudinal data, and regulatory rigor drive the future of biomarker discovery and clinical diagnostics.
Using ALS Patient-Derived Motor Neurons to Study TDP-43 Mislocalization
This Q&A Report answers questions from a webinar with Dr. Vera Evanson on iPSC-derived ALS models reproducing hallmark disease phenotypes and their use in evaluating drug responses.
ADC Payload-Linker CMC Process Development Strategy
Hear Dr. Zheng Wei share a comprehensive payload-linker CMC development strategy that covers regulatory guidance, RSM selection, and stage-appropriate quality control to navigate the evolving complexities of ADC design from IND to NDA.
ADCs on The Horizon: The Performance and Prospect of Cell Line Development Platform — AmigoCHO™
Dr. Jiawen Xu presents AsymBio’s AmigoCHO™ platform and "CLD toolbox" strategies designed to accelerate cell line development and overcome CMC bottlenecks for complex antibody and ADC programs.
Clinical Applications of Optical Cerebral Blood Flow Imaging
Join Dr. Chris Favilla as he discusses non-invasive measurement of cerebral blood flow and potential applications.
Using ALS Patient-Derived Motor Neurons to Study TDP-43 Mislocalization
In this webinar, Vera Evanson, PhD presents how iPSC-derived ALS models reproduce hallmark disease phenotypes and their use in evaluating drug responses.
Transcranial Focused Ultrasound Neuromodulation of the Default Mode Network in the Treatment of Depression and Promotion of Wellness
In this webinar, Dr. John Allen will introduce how low-intensity transcranial focused ultrasound (litFUS), a non-invasive, high-precision neuromodulation technique, has the potential to modulate Default Mode Network (DMN) activity. Emerging evidence suggests that litFUS may reduce Repetitive Negative Thinking (RNT) and mood-related symptoms in clinical populations, and also promote emotional wellness in nonclinical groups.
Human Biological Samples in Research: Quality, Compliance, and Clinical Relevance
In this webinar, three experts discuss best practices for ensuring specimen integrity, leveraging biobanking for oncology breakthroughs, and enriching clinical data for translational research.
From Single Domain to Single B: Leveraging Biointron’s Expertise for Antibody Discovery Success
In this webinar, we present Biointron’s proven expertise in two discovery approaches: VHH Phage Display for single-domain antibody generation and AbDrop® Single B Cell Screening for rapid antibody discovery.
Non CYP Mediated Metabolism Pathways and In Vitro Evaluation Strategies
Discover non-CYP metabolism pathways, key enzymes, and in vitro strategies for safer drug development in this webinar.
Uniting biology and digital drug discovery to identify new therapeutic opportunities in neurodegeneration
As the FDA and NIH encourage a shift away from animal testing, there’s growing momentum behind New Approach Methodologies (NAMs) — from advanced in vitro models to computational platforms. In this webinar, Concept Life Sciences and Delta4 present a powerful example of what this future looks like in practice.
